Mendelian randomization of circulating proteome identifies actionable targets in heart failure
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2164
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Mendelian randomization of circulating proteome identifies actionable targets in heart failure ; volume:23 ; number:1 ; day:13 ; month:8 ; year:2022 ; pages:1-12 ; date:12.2022
BMC genomics ; 23, Heft 1 (13.8.2022), 1-12, 12.2022
- Creator
-
Moncla, Louis-Hippolyte Minvielle
Mathieu, Samuel
Sylla, Mame Sokhna
Bossé, Yohan
Thériault, Sébastien
Arsenault, Benoit J.
Mathieu, Patrick
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12864-022-08811-2
- URN
-
urn:nbn:de:101:1-2022103119383028010850
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Moncla, Louis-Hippolyte Minvielle
- Mathieu, Samuel
- Sylla, Mame Sokhna
- Bossé, Yohan
- Thériault, Sébastien
- Arsenault, Benoit J.
- Mathieu, Patrick
- SpringerLink (Online service)
Other Objects (12)
Proteome-wide mendelian randomization identifies novel therapeutic targets for chronic kidney disease
Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases
Multicenter proteome-wide Mendelian randomization study identifies causal plasma proteins in melanoma and non-melanoma skin cancers
Proteome-wide Mendelian randomization identified potential drug targets for migraine
Proteome-wide Mendelian randomization and therapeutic targets for bladder cancer
Proteome-wide mendelian randomization study implicates therapeutic targets in common cancers
Exploring potential therapeutic targets for asthma: a proteome-wide Mendelian randomization analysis
Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma
Single-cell and genome-wide Mendelian randomization identifies causative genes for gout
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for hyperemesis gravidarum
Systematic proteome-wide Mendelian randomization to prioritize causal plasma proteins for skin cancers
Proteome-wide mendelian randomization identifies novel therapeutic targets for chronic kidney disease
Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases
Multicenter proteome-wide Mendelian randomization study identifies causal plasma proteins in melanoma and non-melanoma skin cancers
Proteome-wide Mendelian randomization identified potential drug targets for migraine
Proteome-wide Mendelian randomization and therapeutic targets for bladder cancer
Proteome-wide mendelian randomization study implicates therapeutic targets in common cancers
Exploring potential therapeutic targets for asthma: a proteome-wide Mendelian randomization analysis
Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma
Single-cell and genome-wide Mendelian randomization identifies causative genes for gout
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for hyperemesis gravidarum
Systematic proteome-wide Mendelian randomization to prioritize causal plasma proteins for skin cancers
Proteome-wide mendelian randomization identifies novel therapeutic targets for chronic kidney disease
Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases
Multicenter proteome-wide Mendelian randomization study identifies causal plasma proteins in melanoma and non-melanoma skin cancers
Proteome-wide Mendelian randomization identified potential drug targets for migraine
Proteome-wide Mendelian randomization and therapeutic targets for bladder cancer
Proteome-wide mendelian randomization study implicates therapeutic targets in common cancers
Exploring potential therapeutic targets for asthma: a proteome-wide Mendelian randomization analysis
Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma
Single-cell and genome-wide Mendelian randomization identifies causative genes for gout
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for hyperemesis gravidarum